3 male and female patient will be eligible for enrollment female should be either of nonchildbearing potential a a result of surgery or menopause 1 year after onset or of childbearing potential and practice a medically acceptable method of contraception e.g. abstinence a barrier method plus spermicide or intrauterine device iud for at least 1 month before visit 1 screening and for 1 month after the end of the study they must also have a negative serum beta-human chorionic gonadotropin b-hcg at screening those females use hormonal contraceptive must also be use an additional approved method of contraception e.g. a barrier method plus spermicide or iud starting with the baseline phase and continue throughout the entire study period 